Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maraviroc to Augment Rehabilitation Outcomes After Stroke
NCT03172026Phase 3Terminated
- Sponsor
- University of California, Los Angeles
- Start
- Aug 2019
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in stroke comparing Maraviroc Arm with Placebo Arm (2 arms). Primary endpoints: 10 Meter Walk Test and Action Research Arm Test. Started Aug 2019; status: terminated.
02
Drugs
maraviroc
03
Conditions
stroke
Beyond the preview
Go deeper on NCT03172026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03172026.